Jacopo Di Lucente

Jacopo Di Lucente

Auto-generated profile, based on publicly available information

Jacopo Di Lucente

Department of Pathology and MIND Institute, University of California Davis Medical Center, Sacramento, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2018 in Glia
Verified
Journal Article
Closed access
PDF file
JLJacopo Di Lucente
Jacopo Di Lucente
HNHai M. Nguyen
Hai M. Nguyen
HWHeike Wulff
Heike Wulff
LJLee‐Way Jin
Lee‐Way Jin
IMIzumi Maezawa
Izumi Maezawa

16 February 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
JLJacopo Di Lucente
Jacopo Di Lucente
GPGiuseppe Persico
Giuseppe Persico
ZZZeyu Zhou
Zeyu Zhou
LJLee-Way Jin
Lee-Way Jin
JRJon J. Ramsey
Jon J. Ramsey
GCGino Cortopassi
Gino Cortopassi
The Ketogenic Diet (KD) improves memory and longevity in aged C57BL/6 mice. We tested 7 months KD vs. control diet (CD) in the mouse Alzheimer’s Disease (AD) model APP/PS1. KD significantly rescued Long-Term-Potentiation (LTP) to wild-type levels, not by changing Amyloid-β (Aβ) levels. KD’s ‘main actor’ is thought to be Beta-Hydroxy-butyrate (BHB) whose levels rose significantly in KD vs. CD mice, and BHB itself significantly rescued LTP in APP/PS1 hippocampi. KD’s 6 most significant pathways induced in brains by RNAseq all related to Synaptic Plasticity. KD induced significant increases in synaptic plasticity enzymes p-ERK and p-CREB in both sexes, and of brain-derived neurotrophic factor (BDNF) in APP/PS1 females. We suggest KD rescues LTP through BHB’s enhancement of synaptic plasticity. LTP falls in Mild-Cognitive Impairment (MCI) of human AD. KD and BHB, because they are an approved diet and supplement respectively, may be most therapeutically and translationally relevant to the MCI phase of Alzheimer’s Disease.

25 October 2023 in The FASEB Journal
Verified
Journal Article
Closed access
LJLee‐Way Jin
Lee‐Way Jin
JLJacopo Di Lucente
Jacopo Di Lucente
UMUlises Ruiz Mendiola
Ulises Ruiz Mendiola
NSNopparat Suthprasertporn
Nopparat Suthprasertporn
ATAlexey Tomilov
Alexey Tomilov
IMIzumi Maezawa
Izumi Maezawa

11 June 2020 in Glia
Verified
Journal Article
Open access
PDF file
HNHai M. Nguyen
Hai M. Nguyen
JLJacopo di Lucente
Jacopo di Lucente
YCYi‐Je Chen
Yi‐Je Chen
YCYanjun Cui
Yanjun Cui
RIRania H. Ibrahim
Rania H. Ibrahim
HWHeike Wulff
Heike Wulff
Microglia‐mediated inflammation exerts adverse effects in ischemic stroke and in neurodegenerative disorders such as Alzheimer's disease (AD). Expression of the voltage‐gated potassium channel Kv1.3 is required for microglia activation. Both genetic deletion and pharmacological inhibition of Kv1.3 are effective in reducing microglia activation and the associated inflammatory responses, as well as in improving neurological outcomes in animal models of AD and ischemic stroke. Here we sought to elucidate the molecular mechanisms underlying the therapeutic effects of Kv1.3 inhibition, which remain incompletely understood. Using a combination of whole‐cell voltage‐clamp electrophysiology and quantitative PCR (qPCR), we first characterized a stimulus‐dependent differential expression pattern for Kv1.3 and P2X4, a major ATP‐gated cationic channel, both in vitro and in vivo. We then demonstrated by whole‐cell current‐clamp experiments that Kv1.3 channels contribute not only to setting the resting membrane potential but also play an important role in counteracting excessive membrane potential changes evoked by depolarizing current injections. Similarly, the presence of Kv1.3 channels renders microglia more resistant to depolarization produced by ATP‐mediated P2X4 receptor activation. Inhibiting Kv1.3 channels with ShK‐223 completely nullified the ability of Kv1.3 to normalize membrane potential changes, resulting in excessive depolarization and reduced calcium transients through P2X4 receptors. Our report thus links Kv1.3 function to P2X4 receptor‐mediated signaling as one of the underlying mechanisms by which Kv1.3 blockade reduces microglia‐mediated inflammation. While we could confirm previously reported differences between males and females in microglial P2X4 expression, microglial Kv1.3 expression exhibited no gender differences in vitro or in vivo.Main Points: The voltage‐gated K+ channel Kv1.3 regulates microglial membrane potential. Inhibition of Kv1.3 depolarizes microglia and reduces calcium entry mediated by P2X4 receptors by dissipating the electrochemical driving force for calcium.

1 January 2018 in Neurobiology of Disease
Verified
Journal Article
Closed access
CCChao-Yin Chen
Chao-Yin Chen
JLJacopo Di Lucente
Jacopo Di Lucente
YLYen-Chu Lin
Yen-Chu Lin
CLCheng-Chang Lien
Cheng-Chang Lien
MRMichael A. Rogawski
Michael A. Rogawski
LJLee-Way Jin
Lee-Way Jin

1 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
Prasant JenaPrasant Jena
Prasant Jena
TSTahereh Setayesh
Tahereh Setayesh
LSLili Sheng
Lili Sheng
JLJacopo Di Lucente
Jacopo Di Lucente
LJLee Way Jin
Lee Way Jin
Yu-Jui Yvonne WanYu-Jui Yvonne Wan
Yu-Jui Yvonne Wan
It has been shown that the Western diet (WD) induces systemic inflammation and cognitive decline. Moreover, probiotic supplementation and antibiotic treatment reduce diet-induced hepatic inflammation. The current study examines whether shaping the gut microbes by Bifidobacterium infantis (B. infantis) supplementation and antibiotic treatment reduce diet-induced brain inflammation and improve neuroplasticity. Furthermore, the significance of bile acid (BA) signaling in regulating brain inflammation was studied. Mice were fed a control diet (CD) or WD for seven months. B. infantis was supplemented to WD-fed mice to study brain inflammation, lipid, metabolomes, and neuroplasticity measured by long-term potentiation (LTP). Broad-spectrum coverage antibiotics and cholestyramine treatments were performed to study the impact of WD-associated gut microbes and BA in brain inflammation. Probiotic B. infantis supplementation inhibited diet-induced brain inflammation by reducing IL6, TNFα, and CD11b levels. B. infantis improved LTP and increased brain PSD95 and BDNF levels, which were reduced due to WD intake. Additionally, B. infantis reduced cecal cholesterol, brain ceramide and enhanced saturated fatty acids. Moreover, antibiotic treatment, as well as cholestyramine, diminished WD-induced brain inflammatory signaling. Our findings support the theory that intestinal microbiota remodeling by B. infantis reduces brain inflammation, activates BA receptor signaling, and improves neuroplasticity.